carbamates has been researched along with diphenyl in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
GAULTIER, M; LEPERCHEY, F | 1 |
Ali, A; Anderson, MS; Chen, Y; Eveland, SS; Guo, Q; Hammond, ML; Hyland, SA; Latham, MJ; Lu, Z; Milot, DP; Napolitano, JB; Peterson, LB; Sinclair, PJ; Sparrow, CP; Tan, E; Theberge, A; Tong, X; Wright, SD; Xu, SS | 1 |
Bouazzaoui, S; D'Costa, Z; Gaddale, K; Harrison, T; Higgins, C; Mullan, P; O'Rourke, M; Scott, C; Templeman, A; Williams, R; Young, A | 1 |
Agniswamy, J; Amano, M; Ghosh, AK; Mitsuya, H; Osswald, HL; Wang, YF; Weber, IT; Yu, X | 1 |
Armirotti, A; Bandiera, T; Bottegoni, G; Cavalli, A; De Simone, A; Di Martino, RM; Ferraro, M; Micoli, A; Ottonello, G; Ruda, GF; Russo, D; Summa, M | 1 |
5 other study(ies) available for carbamates and diphenyl
Article | Year |
---|---|
[Preliminary data on the use in clinical practice of cyclarbamate (N,N-diphenyl dicarbamate of 1,1-cyclopentanedimethanol].
Topics: Alcohols; Biphenyl Compounds; Carbamates; Cycloparaffins; Diphenhydramine; Muscle Relaxants, Central | 1962 |
Design of a novel class of biphenyl CETP inhibitors.
Topics: Animals; Benzylamines; Biphenyl Compounds; Carbamates; Cholesterol Ester Transfer Proteins; Disease Models, Animal; Drug Design; Lipoproteins, HDL; Mice; Mice, Transgenic; Structure-Activity Relationship | 2010 |
P3 SAR exploration of biphenyl carbamate based Legumain inhibitors.
Topics: Biphenyl Compounds; Carbamates; Cysteine Endopeptidases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Molecular Structure; Structure-Activity Relationship | 2014 |
Structure-based design of potent HIV-1 protease inhibitors with modified P1-biphenyl ligands: synthesis, biological evaluation, and enzyme-inhibitor X-ray structural studies.
Topics: Binding Sites; Biphenyl Compounds; Carbamates; Crystallography, X-Ray; Drug Design; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Ligands; Models, Molecular; Molecular Dynamics Simulation; Molecular Structure; Protein Conformation; Stereoisomerism; Structure-Activity Relationship; Sulfonamides; Urethane | 2015 |
Design, Synthesis, Structure-Activity Relationship Studies, and Three-Dimensional Quantitative Structure-Activity Relationship (3D-QSAR) Modeling of a Series of O-Biphenyl Carbamates as Dual Modulators of Dopamine D3 Receptor and Fatty Acid Amide Hydrolas
Topics: Amidohydrolases; Animals; Biphenyl Compounds; Blood-Brain Barrier; Carbamates; CHO Cells; Cricetulus; Drug Design; HEK293 Cells; Humans; Male; Models, Molecular; Piperazine; Piperazines; Quantitative Structure-Activity Relationship; Rats, Sprague-Dawley; Receptors, Dopamine D3 | 2017 |